BioCentury
ARTICLE | Clinical News

Leptin: Phase I

May 12, 2003 7:00 AM UTC

INSERM started a Phase I study in 8-10 children 1.5-15 years old. Amgen Inc. (AMGN, Thousand Oaks, Calif.) is supplying r-metHuLeptin. ...